Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.819 USD | +1.24% | +2.12% | -26.22% |
Mar. 15 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
Business Summary
Number of employees: 186
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
CytoSorb
85.3
%
| 29 | 82.4 % | 31 | 85.3 % | +8.55% |
Grant
14.5
%
| 5 | 15.4 % | 5 | 14.5 % | -1.21% |
Other
0.2
%
| 1 | 2.3 % | 0 | 0.2 % | -91.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other Countries
49.7
%
| 16 | 45.6 % | 18 | 49.7 % | +14.08% |
Germany
35.7
%
| 13 | 36.2 % | 13 | 35.7 % | +3.17% |
United States
14.7
%
| 6 | 18.2 % | 5 | 14.7 % | -15.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Chief Tech/Sci/R&D Officer | 55 | 20-04-30 | |
Steven Sisk
CTO | Chief Tech/Sci/R&D Officer | - | 15-08-17 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
James Komsa
PRN | Corporate Officer/Principal | - | 21-01-10 |
Corporate Officer/Principal | - | 13-04-14 | |
Sales & Marketing | - | 12-08-12 | |
General Counsel | 69 | 23-01-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
Alan Sobel
BRD | Director/Board Member | 63 | 14-11-12 |
Jiny Kim
BRD | Director/Board Member | 47 | 22-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,306,415 | 49,213,952 ( 90.62 %) | 0 | 90.62 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.22% | 43.93M | |
+8.07% | 218B | |
+6.59% | 182B | |
+11.26% | 132B | |
+26.57% | 108B | |
+13.35% | 52.98B | |
-0.62% | 47.59B | |
-0.93% | 39.96B | |
+11.54% | 39.22B | |
+26.76% | 26.94B |
- Stock Market
- Equities
- CTSO Stock
- Company Cytosorbents Corporation